MedTrace Logo

Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)

NCT02749864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12246

Last updated 2018-09-26

No results posted yet for this study

Summary

The hypothesis of this investigation stresses that the current understanding of the prevalence of HCV infection in the general population and in different subgroups will serve to lay out medium- and long-term measures for action geared toward reducing the disease burden through preventive, research, screening and therapeutic measures.

Aim: To determine the prevalence of seropositivity and chronic infection with the HCV and to analyze the associated factors. To analyze and infer different screening strategies for HCV infection based on the at-risk groups/cohorts of elevated prevalence detected. to assess the efficiency of screening strategies and the subsequent cost-effectiveness of treatment in the general population

Conditions

Sponsors & Collaborators

  • Instituto de Investigación Marqués de Valdecilla

    lead OTHER

Principal Investigators

  • Javier Crespo García, MDPhD · Head of Gastroenterology and Hepatology at Hospital Universitario Marqués de Valdecilla. Professor at the Universidad de Cantabria

  • Jose L Calleja, MDPhD · Head of Gastroenterology and Hepatology at Hospital Universitario Puerta de Hierro-Majadahonda

  • Miguel A Serra, MDPhD · Gastroenterology and Hepatology Department at Hospital Clínico U. de Valencia

Eligibility

Min Age
20 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2017-04-01
Completion
2017-04-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02749864 on ClinicalTrials.gov